NIH Notices

Notices

  • Request for Information on the Development of the FY 2019 Trans-NIH Plan for HIV-Related Research
    (NOT-OD-17-053) Office of AIDS Research
  • Notice of Correction for RFA-OD-17-002 “Center for Coordination of Analytics, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54)”
    (NOT-OD-17-054) National Institutes of Health
    Office of Disease Prevention
  • Notice of Correction for RFA-OD-17-006 “Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54)”
    (NOT-OD-17-055) National Institutes of Health
    Office of Disease Prevention
  • Guidance for Adjustments to Appointment Records in xTrain to Reflect Stipend Level Increases for Postdoctoral Trainees on Institutional Ruth L. Kirschstein National Research Service Awards (NRSA)
    (NOT-OD-17-057) National Institutes of Health
  • Notice of Form Correction for PA-16-286 “Successor-in-Interest (Type 6 Parent)”
    (NOT-OD-17-058) National Institutes of Health
  • Notice of Intent to Publish a Funding Opportunity Announcement for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers Research Centers (P50)
    (NOT-AR-18-006)
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Heart, Lung, and Blood Institute
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute of Neurological Disorders and Stroke
  • Notice of Intent to Publish a Funding Opportunity Announcement for Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21)
    (NOT-AR-18-007)
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • Notice of Informational Webinars for Investigators Applying for NCCIH Clinical Trials
    (NOT-AT-17-009)
    National Center for Complementary and Integrative Health
  • Notice of Change to Key Dates in PAR-16-111 “Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy (U01)”
    (NOT-CA-17-048)
    National Cancer Institute
  • Notice of Pre-application Webinar for PAR-16-131 Emerging Questions in Cancer Systems Biology (U01)
    (NOT-CA-17-049)
    National Cancer Institute
  • Notice of Change in the Expiration Date for PA-14-162 “Effects of Cannabis Use and Cannabinoids on the Developing Brain (R21)”
    (NOT-DA-17-017)
    National Institute on Drug Abuse
  • Notice of Change in the Expiration Date for PA-14-164 “Effects of Cannabis Use and Cannabinoids on the Developing Brain (R03)”
    (NOT-DA-17-018)
    National Institute on Drug Abuse
  • Notice of Change in the Expiration Date for PA-14-163 “Effects of Cannabis Use and Cannabinoids on the Developing Brain (R01)”
    (NOT-DA-17-019)
    National Institute on Drug Abuse
  • Notice of Change in the Expiration Date for PA-14-083 “Neuroimmune Signaling and Function in Substance Use Disorders (R21)”
    (NOT-DA-17-020)
    National Institute on Drug Abuse
  • Notice of Change in the Expiration Date for PA-14-084 “Neuroimmune Signaling and Function in Substance Use Disorders (R01)”
    (NOT-DA-17-021)
    National Institute on Drug Abuse
  • Notice of Change in the Expiration Date for PAR-14-225 Clinical Evaluation of Adjuncts to Opioid Therapies for the Treatment of Chronic Pain (R01)
    (NOT-DA-17-022)
    National Institute on Drug Abuse
    National Center for Complementary and Integrative Health
    National Cancer Institute
  • Notice of Change in the Expiration Date for PA-15-099 “Reductions in Illicit Drug Use and Functional Outcomes (R21/R33)”
    (NOT-DA-17-023)
    National Institute on Drug Abuse
  • RFP Notice: Pharmacokinetic and Pharmacodynamic Studies for Medications Development
    (NOT-DA-17-062)
    National Institute on Drug Abuse
  • Notice to Extend PAR-15-024 “Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01)
    (NOT-DK-17-011)
    National Institute of Diabetes and Digestive and Kidney Diseases
  • Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) (U18)
    (NOT-FD-17-007)
    Food and Drug Administration
  • Notice of NICHD’s Participation in PAR-17-221 “Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25)”
    (NOT-HD-17-011)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Correction for AHRQ Consumer Assessment of Healthcare Providers and Systems V (U18) FOA
    (NOT-HS-17-012)
    Agency for Healthcare Research and Quality

Request for Information (RFI): Input on Opportunities of Engagement of External Stakeholders With the Illuminating the Druggable Genome (IDG) Program
(NOT-RM-17-017)
NIH Roadmap Initiatives

Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s